We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Gastrointestinal: Recurrence of pembrolizumab‐induced severe gastritis after tapering steroid therapy.
- Authors
Okubo, Y; Hosotani, K; Taniguchi, Y; Hara, S; Inokuma, T
- Abstract
(a) Esophagogastroduodenoscopy (EGD) showed a diffuse erythematous and ulcerated mucosa with hemorrhage involving entire remnant stomach. Gastrointestinal: Recurrence of pembrolizumab-induced severe gastritis after tapering steroid therapy Esophagogastroduodenoscopy (EGD) demonstrated a diffuse erythematous and ulcerated gastric mucosa with hemorrhage involving the entire remnant stomach (Fig.
- Subjects
GASTRITIS; DRUG side effects; STEROID drugs; LEUKOCYTE count
- Publication
Journal of Gastroenterology & Hepatology, 2021, Vol 36, Issue 3, p586
- ISSN
0815-9319
- Publication type
Article
- DOI
10.1111/jgh.15248